article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

Forbion raises $1.47bn for two life sciences-focused funds

Pharmaceutical Technology

European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How life sciences benefits from broader healthcare transformation

Bio Pharma Dive

Digital transformation has much to offer life sciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.

article thumbnail

NICE introduces revamped support service for life sciences sector

Pharmaceutical Technology

The UK National Institute for Health and Care Excellence (NICE) unveils refreshed support service, NICE Advice, for the life sciences sector.

article thumbnail

UK boosts life science innovation with £277 million funding

Pharmaceutical Technology

On March 28, the UK government announced that four UK life sciences companies will receive £277 million to help fund and advance manufacturing projects in medical diagnostics and human medicines. This is the first big spend being made from the UK’s Life Sciences Innovative Manufacturing Fund (LSIMF).

article thumbnail

Tiziana Life Sciences plans to assess intranasal foralumab for long Covid

Pharmaceutical Technology

Biotechnology company Tiziana Life Sciences has revealed plans to assess intranasal foralumab as a potential treatment for long Covid. Tiziana Life Sciences chief medical officer Matthew Davis said: “We anticipate entering into a Phase 2a placebo-controlled clinical trial upon successful feedback from the FDA.

article thumbnail

Life sciences inspections and investigations

pharmaphorum

Life sciences inspections and investigations Mike.Hammerton Thu, 16/11/2023 - 10:23 Bookmark this